Introduction to Profhilo Structura
Profhilo Structura marks a significant advancement in facial aesthetics, providing an innovative solution for restoring lost facial volume and contours. Developed by IBSA Derma, this cutting-edge injectable blends high and low molecular weight hyaluronic acid through the proprietary NAHYCO® Hybrid Technology. This new generation of the renowned Profhilo treatment is specifically designed to target and regenerate superficial facial fat, delivering natural and long-lasting results.
What is Profhilo Structura?
Profhilo Structura contains 45 mg of low molecular weight hyaluronic acid and 45 mg of high molecular weight hyaluronic acid in a 2 mL syringe. Unlike other hyaluronic acid fillers, it uses NAHYCO® Hybrid Technology to enhance its ability to restore facial volume and contours without chemically cross-linked molecules, resulting in a more natural appearance compared to traditional dermal fillers.
Uses of Profhilo Structura
Primarily intended for the face, Profhilo Structura is effective in reconstructing and reorienting facial fat to counteract volume loss and support facial bones affected by ageing. The treatment not only restores volume but also improves skin quality, making it firmer and more hydrated.
Benefits of Profhilo Structura:
– Natural Look: Maintains facial fat tissues for a natural appearance.
– Long-lasting Results: Provides extended results, reducing the need for frequent touch-ups.
– No Downtime: Requires no recovery time, allowing patients to resume daily activities immediately.
– Improves Skin Quality: Enhances skin firmness and hydration alongside its volumising effects.
Profhilo vs. Profhilo Structura
While both products are developed by IBSA and utilise hyaluronic acid, Profhilo Structura differs from the original Profhilo in several ways:
* Higher HA Content: Profhilo Structura contains 90 mg/2 mL compared to Profhilo’s 64 mg/2 mL.
* Different Applications: Profhilo acts as an injectable moisturiser and collagen booster, whereas Profhilo Structura targets fat tissue restoration.
* Injection Techniques: Tailored to target fat tissue regeneration, enhancing midface projection and reducing hollows and laxity.
Profhilo and Profhilo Structura can be used in separate sessions as a combination treatment, providing optimal results by leveraging the strengths of both injectables.
Clinical Evidence and Launch
Clinical trials of Profhilo Structura have shown impressive results, with 95% of patients noticing significant improvements in the midface area after the first treatment, sustained over three months. This advanced treatment was launched on June 4th in London, marking its European debut nearly a decade after the original Profhilo was introduced by UK and Ireland distributor HA-Derma.
‘Profhilo is a trusted leader in aesthetic medicine,’ says Iveta Vinkler, Sales and Marketing Director at HA-Derma. ‘While fat often carries negative connotations, it’s actually a crucial marker of youth. Our insights into its role in youthful aesthetics are advancing rapidly. The launch of Profhilo Structura equips medical professionals with a natural product tailored to meet the evolving demands of today’s discerning aesthetic clients.’
Conclusion
Profhilo Structura is a groundbreaking addition to non-surgical aesthetic procedures, offering a natural and effective method to regain facial volume and shape. Astrum Medical Clinic in London provides both Profhilo and Profhilo Structura treatments, ensuring patients achieve natural results with minimal recovery time. Embrace the future of facial aesthetics with Profhilo Structura, and rediscover a youthful, sculpted appearance.
